Australian Clinical Labs Limited (ACL.AX)

2.4900 +0.0500 (+2.05%) 收市：04:10PM AEST

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 1 3004 53688
https://www.clinicallabs.com.au

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 5,115

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Melinda McGrath	CEO & Executive Director	1.01M	無	無
Mr. James Davison	Chief Financial Officer	540.69k	無	無
Mr. Anthony Friedli	Chief Operating Officer	無	無	無
Mr. Sean Jackson	Chief Information Officer	無	無	無
Mr. Joe Geran	National Marketing Director	無	無	無
Associate Prof. Tony Landgren	National Medical Director & Chief Pathologist	無	無	無
Mr. Chris Brownlow	Chief Executive Officer of New South Wales & Australian Capital Territory	無	無	無
Ms. Shae Seymour	Chief Executive Officer of Western Australia	無	無	無
Mr. Eric Swayn	Chief Executive Officer of South Australia & Northern Territory	無	無	無
Ms. Eleanor Padman B.A., FCIS	Company Secretary	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 AUD。

描述

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

公司管治

截至 無 止，Australian Clinical Labs Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。